COVID-19 ACTIV-4 ACUTE: A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19 (ACTIV4A)

Description

This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic strategies for prevention of adverse outcomes in COVID-19 positive inpatients.

Summary

PlatformsBDC

Consent CodesGRU

Focus / DiseasesCOVID-19

Study DesignInterventional

Data Types--

Subjects1,083

Applying For Access

dbGaP FAQ dbGaP Access Request Video Tutorial